Your browser doesn't support javascript.
Show: 20 | 50 | 100
Results 1 - 1 de 1
Filter
Add filters
Database
Language
Document Type
Year range
1.
Post-severe Acute Respiratory Syndrome Coronavirus 2 Monoclonal Antibody Treatment Hospitalizations as a Sentinel for Emergence of Viral Variants in New York City.
Cowman, Kelsie; Guo, Yi; Pirofski, Liise-Anne; Wong, David; Bao, Hongkai; Chen, Victor; Hopkins, Una; Andrews, Erin; Hamel, Joseph; Keller, Marla; Bellin, Eran; Thota, Raja; Davis, Patricia; Rodriguez, Edwin Torres; Suthar, Pooja; Allen, Lauren; Rossi, James; Haviland, Adam; Orner, Erika; Szymczak, Wendy; Shujauddin, Sadahf; McCarthy, James; Binder, Barbara; Pushparaj, Vanitha; Bard, Linda; Pierino, Vincent Frank; Alsina, Leslie; Esses, David; McCaskie, Alicia; Campbell, Caron; Madzura, Tabitha; Wollowitz, Andrew; Basset, Kelly; White, Deborah; Ruiz, Rafael; Sosnowski, Frank; Nori, Priya.
Open Forum Infect Dis ; 8(8): ofab313, 2021 Aug.
Article in English | MEDLINE | ID: covidwho-1377978

ABSTRACT

We partnered with the US Department of Health and Human Services to treat high-risk, nonadmitted coronavirus disease 2019 (COVID-19) patients with bamlanivimab in the Bronx, New York per Emergency Use Authorization criteria. Increasing posttreatment hospitalizations were observed monthly between December 2020 and March 2021 in parallel to the emergence of severe acute respiratory syndrome coronavirus 2 variants in New York City.

SEND TO:
Email
Export
Print
RSS
XML
SELECTION OF CITATIONS
SEARCH DETAIL